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Abstract
Background: The FGF/Ras/Ral/RLIP pathway is required for the gastrulation process during the early development of
vertebrates. The Ral Interacting Protein (RLIP also known as RalBP1) interacts with GTP-bound Ral proteins. RLIP/RalBP1 is a
modular protein capable of participating in many cellular functions.
Methodology/Principal Findings: To investigate the role of RLIP in early development, a two-hybrid screening using a
library of maternal cDNAs of the amphibian Xenopus laevis was performed. Xreps1 was isolated as a partner of RLIP/RalBP1
and its function was studied. The mutual interacting domains of Xreps1 and Xenopus RLIP (XRLIP) were identified. Xreps1
expressed in vivo, or synthesized in vitro, interacts with in vitro expressed XRLIP. Interestingly, targeting of Xreps1 or the
Xreps1-binding domain of XRLIP (XRLIP(469–636)) to the plasma membrane through their fusion to the CAAX sequence
induces a hyperpigmentation phenotype of the embryo. This hyperpigmented phenotype induced by XRLIP(469–636)-
CAAX can be rescued by co-expression of a deletion mutant of Xreps1 restricted to the RLIP-binding domain (Xreps1(RLIP-
BD)) but not by co-expression of a cDNA coding for a longer form of Xreps1.
Conclusion/Significance: We demonstrate here that RLIP/RalBP1, an effector of Ral involved in receptor-mediated
endocytosis and in the regulation of actin dynamics during embryonic development, also interacts with Reps1. Although
these two proteins are present early during embryonic development, they are active only at the end of gastrulation. Our
results suggest that the interaction between RLIP and Reps1 is negatively controlled during the cleavage stage of
development, which is characterized by rapid mitosis. Later in development, Reps1 is required for the normal function of the
ectodermic cell, and its targeting into the plasma membrane affects the stability of the ectoderm.
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Introduction
During oogenesis, large amounts of RNAs, necessary for early
development, accumulate. These stored maternal mRNAs are
used to support protein synthesis during the first few hours of
development, before the onset of embryonic transcription and up
to gastrulation. Among the products of these genes, different
components of the fibroblast growth factor (FGF) transduction
pathway are present, such as Ras and members of the MAPK
family, to ensuring quick responses of the vegetal inducing signals
during the mesodermal induction. Previously [1], we character-
ized, from a subtractive library enriched in maternal mRNA, a
new gene encoding a protein that belongs to the FGF/Ras
pathway and that is involved in early development [2]. The FGF
signaling plays a key role during early development of vertebrates,
where it has been implicated in a large number of processes such
as induction, patterning of the three germ layer and control of
morphogenetic movements. In Xenopus laevis embryos FGF
signaling was shown to be required for two developmental
processes through the involvement of different effectors of Ras: i)
mesodermal gene expression through Raf [3] and PI3 kinase [4],
and ii) cell movements of gatrulation through the Ral guanine
nucleotide dissociation stimulator (RalGDS), which modulates the
dynamics of the actin cytoskeleton [5]. RalGDS is a guanine
exchange factor (GEF) that can activate the Ral proteins [2], that
are members of the superfamily of the Ras small G proteins.
Several effectors that bind specifically to the activated form of the
Ral proteins have been identified, and they are involved in
different cell processes such as protein secretion or endocytosis [6],
[7], [8]. The Ral Interacting Protein (RLIP also known as RalBP1)
[9] [10], [11] interacts with GTP-bound RalA and RalB. The
Xenopus RLIP (XRLIP) has been cloned and its primary sequence
is 85% identical to the mammalian RLIP76 [12]. During
gastrulation of Xenopus embryos, XralB [2] and RLIP [12] are
involved in modulating the stability of cortical actin assembly.
Moreover, RalB requires RLIP for morphogenetic movements at
this stage.
RLIP/RalBP1 is a modular protein capable of participating in
many cell functions (Fig. 1). It contains a RhoGAP domain that
enhances the GTPase activity of two members of the subfamily of
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are regulators of the actin cytoskeleton and are also involved in
many cell processes, such as membrane trafficking (for a review see
[13]). RLIP also binds to the m2 subunit of the heterotetrameric
clathrin adaptor (AP-2 complex) [14] and to the proteins Reps1
[15] and POB1 (also known as Reps2) [16]. Reps1 and POB1/
Reps2 share only 38% sequence identity. However, they both
contain an Eps15 homology (EH) domain involved in protein-
protein interactions, and also polyproline stretches and a coiled-
coil domain located in the same order. POB1 interacts directly
with Eps15 and Epsin (for reviews see [17], [18]) and Reps1
probably does so as well [19]. Eps15 and Epsin, and their yeast
orthologs Pan1 and End3, are essential components of the
endocytotic machinery. They can interact with each other and
with the clathrin-recruiting AP-2 complex, necessary for endocy-
tosis. Indeed, RLIP and POB1 as well as RalA are involved in the
endocytosis of various receptors [20], [14], [21]. RLIP is
overexpressed in several tumor cells such as prostate, melanoma,
lung and bladder cells, as well as in cancer cell metastasis [22],
[23].
We have previously shown that XralB can affect the stability of
the F-actin network in Xenopus embryos [2] and that it is required
for the morphogenetic movements during gastrulation [5].
Similarly to Ral, RLIP induces cortical actin disruption when it
is targeted to the plasma membrane to mimic its cellular
interaction with Ral [12]. Since RLIP is an effector of Ral present
in early development and is required for gastrulation, we have
attempted to uncover other proteins involved in this function.
Using a two-hybrid screen to identify XRLIP partners in early
development, the Xenopus ortholog of Reps1 (referred to as
Xreps1(253)) was isolated. Whereas Xreps1 and XRLIP interact
in vitro, this interaction cannot be detected in vivo before
gastrulation. Interestingly, although Xreps1(253) is presumably
not involved in the action of XRLIP during gastrulation, it
suppresses the phenotype induced by N-terminally truncated (DN-
terminal) XRLIP mutants. The lack of phenotypic effect due to
overexpression of Xreps1(253) or mouse Reps1 (Mreps1) indicates
that this protein is not active before the mid blastula transition
(MBT), and that later in development its cellular function could be
restricted to ectodermic cells. Indeed, targeting Xreps1(253) or
Mreps1 to the plasma membrane causes a persistent hyperpig-
mentation of ectodermic cells. Since membrane localization of
Xreps1(253) relies on its interaction with XRLIP, we suggest that
the interaction between these two proteins is required for a
function of ectodermic cell after MBT.
Results
Characterization of the interaction between XRLIP and
Xreps1(253)
To identify proteins that might participate in early development
through binding to RLIP, we screened a Xenopus cDNA library
constructed at different stages of oogenesis and early development
[25] using the yeast two-hybrid system with the full-length human
RLIP76 as the bait [14]. Four cDNAs of different lengths coding
for Xreps1 were isolated. The longest cDNA (clone 253 referred to
as Xreps1(253), Accession number AJ878914 (see below)) codes for
a protein of 513 residues that lacks 229 residues from the N-
terminal region, compared to the murine orthologous protein.
However, this clone that corresponds to a partial coding sequence
of the Reps1 gene, encompasses all the domains previously
characterized in Reps1, including the potential tyrosine-phos-
phorylation sites [15]. Sequence comparisons showed 76% of
identity between the C-terminal two-thirds of the sequences of
Reps1, Mreps1 and Xreps1(253). Identity was higher in the EH
domain, rising to 95% for the 49 most C-terminal amino acids.
The shortest cDNA fragment codes for a polypeptide of 78 amino
acids that overlaps the C-terminal end of Mreps1, including the
putative coiled-coil region (residues 690–743 in mice). This clone
was named Xreps1(RLIP-BD) (see below). A northern blot study
involving RNA samples from stage-VI oocytes to the tadpole
stages and from different tissues, probed with Xreps1(253), showed
that only one type of mRNA (2.7 kbp) was expressed from
oogenesis and throughout development and in the different tissues
such as liver, kidney and heart (data not shown). Thus, Reps1
mRNA is clearly present during oogenesis of Xenopus,a si ti si n
human ovaries [30], and is detected in the same differentiated
tissues tested, such as liver, kidney and heart, as previously
reported by Xu et al [30]. We examined whether Reps1 could
have a spatial expression profile during early Xenopus development
by performing in situ hybridization using an anti-sens Reps1, and
an anti-sens Chordin probe [31] as positive control of the
transcript located. Whereas expression of Chordin is clearly
detected in the dorsal blastoporal lip (Fig. 2c) or in the notochord
(Fig. 2d), Reps1 shows a weak uniform expression (Fig. 2a, b) in
the entire embryo. This result confirms the ubiquitary distribution
of Reps1 in the embryo as observed by northen blot in adult
tissues. The strong sequence identity between Mreps1 and
Figure 1. Interacting domain of RLIP involved in endocytosis.
RLIP through its N-terminal and C-terminal domains interacts with m2,
and POB1 or Reps1 proteins respectively. These proteins interact in turn
with complexes involved in clathrin endocytosis. The RhoGAP sequence
of RLIP controls the Cdc42 activity and the actin dynamic. The Ral
binding domain binds with Ral, in response to activation tyosine kinase
receptor through the activation of the Ras protein.
doi:10.1371/journal.pone.0033193.g001
Figure 2. Reps1 is uniformly expressed in early development. In
situ hybridization of Reps (a and b), and Chordin (c and d) in gastrula (a
and c) and neurula (b and d). Each embryo was hybridized with one
antisens, and one sens probe. Embryos hybridized with the sens probe
are marked with *.
doi:10.1371/journal.pone.0033193.g002
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prompted us to check whether the interaction between RLIP and
Xreps1 was also conserved during amphibian development. First,
a yeast two-hybrid approach was used. Specifically, yeast cells
were co-transformed with plasmids driving the expression of either
human RLIP (known as RLIP76), XRLIP, human Lamin or
human wild-type Hras and, on the other hand, with plasmids
encoding either Xreps1(253), Xreps1(RLIP-BD) or Xreps1
(DRLIP-BD) (Fig. 3A). As shown in Figure 3B, Xreps1(RLIP-
BD) interacted with RLIP76 and XRLIP, as did Xreps1(253),
whereas Xreps1 (DRLIP-BD) failed to bind XRLIP. As expected,
Xreps1(253) was unable to interact with Lamin or Hras, excluding
potential non-specific interactions in the conditions of the two-
hybrid assay. These results showed that i) the interaction between
Xreps1(253) and XRLIP was specific, ii) that the domain
Xreps1(RLIP-BD) was necessary and sufficient for the interaction
to take place and iii) that the interaction Xreps1(253)-XRLIP was
conserved from Xenopus to humans [15].
The RLIP-binding domain of Reps1 has been mapped between
residues 599 and 743 in mice, corresponding to 369 to 513 in the
Xreps1(253) clone [15]. The Xreps1 clone called Xreps1(RLIP-
BD), and corresponding to the fragment 435–513 of the initial
Xreps(253) sequence, retains the ability to interact with XRLIP
(Fig. 3B and C). Interestingly, Xreps1(RLIP-BD) is nearly half the
length of the previously defined RLIP-binding domain of Reps1
[15]. The identification of such a minimal RLIP-BD in Xreps1
raises the possibility of using this small domain in vivo as a negative
competitor of its endogenous full-length counterpart.
The Reps1-binding domain of RLIP was previously mapped
between residues 500 to 647, which corresponds to positions 481
to 628 of our XRLIP clone. Attempts were made to better define
the size of this interacting domain by testing the ability of either
Xrep1(253), Xreps1(RLIP-BD) or Xreps1(DRLIP-BD) to bind to
different deletion mutants of XRLIP in two-hybrid assays. As
expected, both Xreps1(253) and Xreps1(RLIP-BD) interacted
efficiently with XRLIP(330-Cter) and XRLIP(469-Cter) because
these deletion mutants contain the previously described binding
region. However, they failed to bind to a truncated version of
XRLIP (XRLIP(1–323)) used as control and containing only the
m2 binding domain and the RhoGAP region, and lacking the C-
terminal part of the protein. As expected, Xreps1(DRLIP-BD)
did not interact with any of the XRLIP mutants (Fig. 3C).
Interestingly, Xreps1 interacted with an XRLIP deletion mutant
containing only the RhoGAP and RalBD (i.e. XRLIP(172–495)).
The most C-terminal part of RalBD of XRLIP contains 14
amino acids also present in the Reps-BD, as mentioned above.
This suggests that the region of interaction with Reps involves
only 14 amino acids located between residues 481 and 495 of
XRLIP. To confirm this possibility, we tested in a two-hybrid
assay whether XRLIP deleted of the region between amino acids
475 and 492 still had the capacity to bind Xreps1(253). As
expected, the construct deleted for this region, XRLIP 172-Cter
(D475–492), failed to bind to Xreps1(253) (Fig. 3C). This clearly
shows that both regions of XRLIP comprised between amino
acids 475 and 492, as well as the C-terminal portion of Xreps1
are necessary to mediate the interaction between these two
proteins.
XRLIP and Xreps1(253) interact in vitro
To verify whether the interactions observed using the two-
hybrid technique take place in vitro, pull-down assays were
performed involving Xreps1(253) and XRLIP. Xreps1(253) and
XRLIP were synthesized either in bacteria as GST-fusion
proteins, or in reticulocyte extracts as Myc-tagged proteins.
Specifically, purified recombinant GST-XRLIP was mixed with
either reticulocyte-synthesized or embryo-synthesized Myc-
Xreps1(253) or Myc-Xreps1(RLIP-BD). The presence of the latter
proteins was detected in the GST-pull-down pellets (Fig. 4A, B).
The supernatants were almost completely depleted of Myc-
Xreps1(253) or Myc-Xreps1(RLIP-BD). No trace of either Myc-
Xreps1(253) or Myc-Xreps1(RLIP-BD) could be detected in the
pull-down pellets when using purified GST alone. These results
show that GST-XRLIP can interact with Myc-Xreps1(253) in vitro.
Moreover, the interaction between the two partners is sufficiently
strong for XRLIP to recover virtually all the available Myc-
Xreps1(253).
As XRLIP synthesized in reticulocyte lysates binds Xreps1(253),
we explored whether the formation of the XRLIP/Xreps1(253)
complex takes place in vivo in Xenopus embryos. Xenopus embryos
microinjected with mRNAs coding for Myc-Xreps1(253) or Myc-
Xreps1(RLIP-BD) at the 2-cell stage were taken at stage 6–7
(cleavage stage) and expression of the proteins was assessed by
Western blot (Fig. 4C). These lysates were used as substrates for
co-immunoprecipitation assays and the presence of endogenous
wild-type XRLIP was searched in the immunoprecipitation pellets.
XRLIP could be very faintly but reproducibly detected in the
pellets precipitated in vivo only with Myc-Xreps(RLIP-BD)
(Fig. 4C).
Since recombinant proteins can be produced in sufficient
amounts in the embryo, we tested the capacity of in vivo-
synthesized XRLIP to interact with Reps1. For this, the GST
pull-down technique was used. Specifically, purified recombinant
GST-Xreps1(253) or GST-Xreps1(RLIP-BD) was added to cell
lysates of Xenopus embryos harvested at stage 6–7. A clear but weak
Myc-XRLIP band was detected when using 2 mg of either GST-
Xreps1(253) or GST-Xreps1(RLIP-BD) (Fig. 4D). To determine
whether these results could be observed at others stages of
embryonic development or if they were specific of the cleavage
stage, similar experiments were conducted with cell lysates from
gastrula stage embryos as well as from stage-VI oocytes, and
similar results were obtained in all cases (not shown).
To control the efficiency of the pull-down tests, the interaction
of Myc-RLIP with GST-XralA G23V, which corresponds to the
activated form of RalA, was used. The purified recombinant GST-
XralA G23V was preloaded with GTP-g-S and then added to cell
lysates of embryos or oocytes at the same stages as described
above. Analysis of the pull-down pellets showed that XRLIP was,
as expected, present in pellets corresponding to GST-XralA G23V
and that the amount of co-precipitated XRLIP did not seem to
vary with the stage of the sample. However, as for the endogenous
protein, only a small fraction of exogenous Myc-XRLIP was
present in these pellets (Fig. 4D). These results summarized in
Figure 4E lead to several conclusions. First, the interaction
between XRLIP and Xreps1(253) can take place in vitro and does
not seem to require a third partner. Second, the interaction seems
to be more efficient when XRLIP is synthesized in bacteria or
yeast. Third, in the embryo only a minor fraction of endogenous
XRLIP appears to be available for interaction, whatever the
nature of the partner RalA-GST or Xreps). Fourth, the formation
of XRLIP-Xreps1(253) complexes during the cleavage stage seems
to occur in amounts so low that it almost escapes detection. The
previously well-documented interaction between RLIP and GTP-
bound Ral takes place in embryos [12]. However, since only a
small fraction of endogenous XRLIP seems to be involved in these
interactions, we hypothesize that endogenous XRLIP could be in
an inert state with regard to Reps. Furthermore, interaction of
XRLIP with Reps might be regulated by post-translational
modifications.
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Xreps1(253) is a bona fide partner of XRLIP and is expressed
during development. To test whether its over-expression induces a
particular phenotype, we microinjected mRNAs coding for the N-
terminally Myc-tagged proteins Myc-Xreps1(253) or Myc-
Xreps1(RLIP-BD) into the animal pole of one blastomere of
embryos at the 2-cell stage. The injected embryos were monitored
for visible defects in aspect and/or development throughout
embryogenesis up to stage 40. Whatever the amount of mRNA
injected, over-expressed Xreps1(253) (up to 3 ng/embryo) caused
Figure 3. Interaction analysis of XRLIP with Xreps1 by the two-hybrid technique. (A) Schematic representation of the XRLIP and
Xreps1(253) deletion mutants used here. For XRLIP, a distinctive box represents each interacting domain. For Xreps1(253), the grey box corresponds
to the EH homology domain and the black box to the coiled-coil motif. (B) Two-hybrid assay between Xreps1(253), Xreps1(RLIP-BD) or Xreps1(DRLIP-
BD) and human RLIP (RLIP76), Xenopus RLIP (XRLIP), or Lamin or human Ras (Hras) as controls. (C) Two-hybrid assay between Xreps1(253),
Xreps1(RLIP-BD) or Xreps1(DRLIP-BD) with different deletion mutants of XRLIP or Lamin as control.
doi:10.1371/journal.pone.0033193.g003
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late development (data not shown). Likewise, over-expression of
the RLIP-binding peptide Xreps1(RLIP-BD) caused no pertur-
bation (Fig. 5Ab). Similar results were obtained with over-
expression of Mreps (Fig. 4Ad). To test if the injected mRNAs
were correctly translated, the expression of the exogenous
proteins was assessed by Western blot using a monoclonal anti-
Myc antibody (Fig. 5B). The two Xreps1 mutant proteins were
expressed within hours following microinjection but they did not
display the same electrophoretic migration properties. Myc-
Xreps1(RLIP-BD) was expressed as a single 25 kDa peptide
(Fig. 5B lane b), 12 kDa larger than its theoretical size, as was the
case when it was synthesized using reticulocyte extracts (Fig. 5B
lane e). The 25 kDa protein was stable and accumulated with
time. Myc-Xreps1(253) was expressed as a major 85 kDa product
(Fig. 5B lane c), 30 kDa larger than its theoretical size, as was also
the case in reticulocyte extracts (Fig. 5B lane f), The 85 kDa
protein accumulated with time, but very soon after microinjection
several lower-sized Myc-containing peptides could be detected
(Fig. 5B lane c). However, these lower-sized Myc-containing
peptides did not accumulate in reticulocyte extracts (Fig. 5B lane
f), suggesting that in early embryos, Xreps1(253) undergoes either
proteolytic processing or partial degradation. In embryos,
Xreps1(253) seemed to be translated much more efficiently than
Xreps1(RLIP-BD).
Taken together, these data indicate that over-expression of the
cloned partial Xreps1(253) or full-length Mreps1 sequences has
no obvious effects on embryogenesis. Also intriguing is the lack of
effect of over-expression of the RLIP-BD of Xreps1. This result
suggests that this peptide might not act as expected by preventing
normal interaction between endogenous XRLIP and endogenous
Xreps1(253). Another possibility is that Reps might need to be in
a particular cellular location to properly function. To test this
possibility, and since Reps interacts with RLIP and that RLIP
interacts with the RalB protein at the plasma membrane, Mreps1
was fused to a CAAX sequence to target it artificially to the
plasma membrane. Mreps1-CAAX was then over-expressed in
embryos. Up to MBT, no phenotype could be seen, but later,
ectodermal cells became hyperpigmented (Fig. 5Ae and f). This
hyperpigmentation persisted throughout development to the
tadpole stage (endpoint of the observations made) without
inducing developmental failure. At hatching, the hyperpigmented
cells became labile and the ectoderm of the tadpole became
brittle.
Figure 4. Characterization of the Xreps1(253) domain critical for interaction with XRLIP, and interaction in vivo of Xreps1(253) and
Xreps1(RLIP-BD) with XRLIP. (A, B) GST-XRLIP or GST alone as control were tested for their ability to pull down Xreps1(253) or Xreps1(RLIP-BD)
synthesized as Myc-tagged proteins. The interaction of XRLIP with RalB G23V served as positive control. Xreps1(253) precipitated with 1 mg GST-XRLIP
was analyzed. (A) The input or supernatant ranged from 1.25 ml of the 25 ml of reticulocyte extract), or (B) half an embryo from extracts of 10 embryos,
were analyzed by SDS-PAGE. (C) Myc-Xreps1(253) or Myc-Xreps1(RLIP-BD) were synthesized in embryos and used to interact with endogenous XRLIP.
Total lysate from 10 embryos were incubated with an anti-Myc agarose-conjugated antibody (SC-40, Santa Cruz Biotechnology) and centrifuged. The
supernatant and immunoprecipitated proteins were resolved by SDS-PAGE and immunoblotted with anti-RLIP, or anti-Myc antibodies. With Myc-
Xreps1(RLIP-BD), the RLIP signal was weakly detected just above an unspecific signal (,). (D) Two mg of GST-Xreps1(253), GST-Xreps1(RLIP-BD), or
1 mg of GST-XralA (G23V) preloaded using GTP-g-S, or GST alone were incubated with Myc-XRLIP (lysate from 10 embryos) and purified with
glutathione-agarose beads. The precipitated proteins were resolved by SDS-PAGE, transferred onto a Hybond-P membrane (Amersham) and blotted
with a monoclonal anti-Myc antibody (9E10). (E) The table recapitulates the results obtained on the in vivo and in vitro interaction of XRLIP with
Xreps1.
doi:10.1371/journal.pone.0033193.g004
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development
The two-hybrid technique showed a clear and unambiguous
interaction between Xreps1(253) and XRLIP and was confirmed
by our GST-pull down experiments. Yet, over-expression of
Xreps1(253) and Mreps1 had no detectable effect on embryo
development. However, both proteins, Xreps and XRLIP, might
accomplish a function, not clearly observable by a discernible
phenotype in our experimental conditions. Moreover, RLIP is a
cytoplasmic protein recruited to the plasma membrane by the
activated form of Ral. This suggests that Reps could be active only
when located in the region of the plasma membrane.
As Mreps1 targeted to the plasma membrane induces a
hyperpigmented phenotype, we first tested whether targeting the
C-terminal region of RLIP containing Reps-BD induced this
phenotype, and then sought to determine the minimal sequence
necessary for this interaction. Specifically, embryos were injected
at the animal pole with different mRNAs (1 ng/blastomere)
coding for deletion mutants of XRLIP and containing a CAAX
sequence. None of these mutants caused any visible perturbation
during early development corresponding to the cleavage stage.
However, as of the MBT, embryos expressing mutant proteins
containing the Reps-BD, such as (XRLIP(469-Cter)), presented an
altered pigmentation (Fig. 6D, E and G). This altered pigmenta-
tion was similar to the phenotype induced by Xreps1-CAAX
(Fig. 5Af) but quite different from that previously observed with
XRLIP-CAAX (Fig. 6B) [11]. These embryos developed almost
normally, often reaching stage 17 (late neural stage) (71%+/212
n=169) and even later stages. The ectoderm composed of
hyperpigmented cells was more fragile and usually broke at later
stages, most often causing the death of the embryos. Clusters of
hyperpigmented cells often detached from the embryo and
remained linked to the vitelline membrane after hatching.
Embryos injected with XRLIP(172–495)-CAAX mRNA, dis-
played the same dotted aspect (Fig. 6E), while XRLIP (499-
Cter)-CAAX induced only very weak hyperpigmentation. This
would seem to rule out the implication of Reps1 in the phenotype
described, but it should be stressed that only the XRLIP(172–495)-
CAAX mutant still contained the 14 residues of the N-terminus of
RepsBD, shown to mediate the interaction with Xreps1. Other
XRLIP deletion mutants containing the interacting domain with
Reps1 as well as full-length Mreps1, both targeted to the
membrane, induced similar hyperpigmentation phenotypes
(Fig. 5Ae and Fig. 6E and G). These results suggest that RLIP
and Reps1 could interact at the plasma membrane to induce the
hyperpigmentation phenotype.
Figure 5. Effect of Xreps1(RLIP-BD) and Xreps1(253) on embryo
pigmentation during gastrulation. (A) Animal views of gastrulae.
Control uninjected embryos (a). Embryos injected in animal pole of one
blastomere at the 2-cell stage with 1 ng mRNA of Myc-Xreps1(RLIP-BD)
(b), Myc-Xreps1(253) (c), Mreps1 (d), or Mreps1-CAAX (e) and
enlargement of hyperpigmented cell area from an embryo injected
with Mreps1-CAAX (f) Red arrows show hypepigmentation area. (B)
Protein expression of Xreps1(RLIP-BD) and Xreps1(253) was analyzed by
Western blot with a 9E10 anti-Myc antibody, control lanes a,
Xreps1(RLIP-BD) b and Xreps1(253) c, and analysis of
35S signal from
reticulocyte extracts; control d, Xreps1(RLIP-BD) e and Xreps1(253) f.
doi:10.1371/journal.pone.0033193.g005
Figure 6. Effect of different mutants of XRLIP mRNAs on
embryo pigmentation and cell division. The upper part describes
the map of cDNA corresponding to the RNA injected. Lower part (A)
uninjected embryos. (B), One blastomere at the 2-cell stage was
injected in animal pole with 1 ng of XRLIP-CAAX and the phenotype of
the embryos at the cleavage stage is presented. (C–H) Animal views of
gastrula embryos injected with the different XRLIP mutants: with (2 ng
of (148–387)-CAAX (C) with 1 ng of (330-Cter)-CAAX (D), with 1 ng of
(172–495)-CAAX (E), with 2 ng (361–461)-CAAX (F), with 2 ng of (469-
Cter)-CAAX (G), and with 2 ng of XRLIP(499-Cter)-CAAX (H). The yellow
arrow-heads indicate hyperpigmented cells in the animal hemisphere.
doi:10.1371/journal.pone.0033193.g006
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Xreps1(RLIP-BD) and synergistic effect of Xreps1(253)
The hyperpigmentation induced by the over-expression of the
XRLIP mutants ((XRLIP(469-Cter)-CAAX, XRLIP(330-Cter)-
CAAX, XRLIP(172–495)-CAAX) and Mreps-CAAX) suggests
that Xreps1 and XRLIP interact close to the plasma membrane to
generate the phenotype. To investigate this possibility, we tested
by co-injection whether the Xreps1(RLIP-BD) mRNA could
compete the endogenous Xreps and rescue the phenotype induced
by the expression of the proteins XRLIP(330-Cter)-CAAX,
XRLIP(172–495)-CAAX, or XRLIP(469-Cter)-CAAX. Interest-
ingly, the hyperpigmented phenotypes induced by XRLIP(172–
495)-CAAX (Fig. 7Aa), XRLIP(330-Cter)-CAAX (Fig. 7Ad), or by
XRLIP(469-Cter)-CAAX (Fig. 7Ag), were almost completely
rescued when Myc-Xreps1(RLIP-BD) was co-injected (Fig. 7Ac,
Af and Ai). Oversized blastomeres were no longer observed and
pigmentation of animal blastomeres was practically undistinguish-
able from that of uninjected embryos. To test whether Xreps1(253)
could synergize the effect of the XRLIP-CAAX deletion mutants
(Fig. 7Aa, d, and g) by itself and not by competing with another
protein, mRNAs coding for these three mutants were co-injected
with mRNA coding for Xreps1(253) (Fig. 7Ab, e, h and k). The
Xreps1(253) sequence weakly amplified the effect of these three
mutants. When XRLIP(172–495)-CAAX, XRLIP(330-Cter)-
CAAX or by XRLIP(469-Cter)-CAAX were injected at doses
unable to cause any visible alteration, co-injection with large
amounts of Xreps1(253) led the appearance of small dotted
patches (Fig. 7 Ab, e and h) characteristic of the phenotype
obtained at higher doses (Fig. 5Ad). Over-expression of
XRLIP(469-Cter)-CAAX induced a weak effect on ectodermal
cells of embryos, but not only was this effect synergistically
increased in the presence of Xreps1(253), but at later stages of
development, during the tailbud stage, the embryo morphology
was affected and ectodermal cells were detached from the
ectoderm (Fig. 7 Ak). To test whether Xreps1(RLIP-BD) could
rescue all the effects of XRLIP-CAAX, mRNAs coding for full-
length XRLIP-CAAX and for Xreps1(RLIP-BD) were co-injected
(not shown). Xreps1(RLIP-BD) did not alter the depigmentation
induced by XRLIP-CAAX (not shown). This indicates that
Xreps1(RLIP-BD) specifically blocks the action of the XRLIP
mutants containing the Reps-BD sequence. Hence, Xreps1(253)
participates in pathways relying on interactions involving the C-
terminal part of XRLIP-CAAX. Moreover, the blocking action of
Xreps1(RLIP-BD) is probably not due to the masking of closely
positioned domains necessary for recruitment of another target
protein, and the 513 N-terminal amino acids of Reps1 are
probably sufficient to induce hyperpigmentation and to arrest
blastomere division.
XRLIP-CAAX translocates Xreps1 to the plasma
membrane by its C-terminal domain
Since biochemical analyses and rescue experiments show that in
vivo Xreps1 interacts weakly with endogenous and exogenous
XRLIP, we investigated whether this interaction was visible in
embryos after the MBT stage. Using confocal microscopy, the
distribution of Xreps1 expressed alone or with the deletion mutant
of XRLIP-CAAX coding for the C-terminal part was examined.
Animal caps dissected from embryos injected with Xreps1(253)
(not shown) or Xreps1(RLIP-BD) (Fig. 8D) revealed that the
localization pattern of the protein was strikingly similar to that of
XRLIP [12]. In some blastomeres both proteins were diffuse
throughout the cell, whereas in others, they were excluded from
the central zone. In other cells Xreps1(253) and Xreps1(RLIP-BD)
localized towards the cell periphery and in their central part, but
the proteins were excluded from a pericentral zone. However, in
all cases they were totally excluded from a zone that seems to
correspond to the cell cortex. When untagged XRLIP(379-Cter)-
CAAX mRNA was co-injected with Myc-tagged Xreps1(RLIP-
BD), the cortical actin of the animal blastomeres was not different
from that of controls (Fig. 8H). This result is identical to that
obtained with XRLIP(330-Cter)-CAAX, previously described.
But, as this mutant contains a sequence that induces the formation
of large ectodermal cells, due in part to the presence of a sequence
that affects cytokinesis (manuscript in preparation), we preferred,
in this experiment to use an mRNA encoding a protein lacking the
amino-acid sequence involved in this additional phenotype.
Nevertheless, there was clear partial localization of Xreps1(R-
Figure 7. Phenotypes induced by XRLIP(172–495)-CAAX,
XRLIP(330-Cter)-CAAX or XRLIP(469-Cter)-CAAX are amplified
by Xreps1(253) and are rescued by Xreps1(RLIP-BD) but not. (A)
The injected embryos were photographed at the gastrula stage.
Embryos at the 2-cell stage were injected (a, d, g) with 1 ng of
respectively XRLIP(172–495)-CAAX, XRLIP(330-Cter)-CAAX or XRLIP(469-
Cter)-CAAX mRNA alone, or co-injected (b, e, h) with 1 ng of
Xreps1(253) mRNA, or co-injected (c, f, i) with 1 ng of Xreps1(RLIP-BD)
mRNA. Only the hyperpigmented phenotype (a, d, g) disappears (c, f, i).
In g and h the yellow arrows show the hyperpigmented cells. (B)
Proteins expression, from embryos injected with XRLIP(469-Cter)-CAAX
alone (j) or respectively co-injected with Xreps (k) and Xreps(RLIP-BD) (l),
were analyzed by Western blot with a 9E10 anti-Myc antibody.
doi:10.1371/journal.pone.0033193.g007
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co-localization with cortical actin, situations never observed when
Xreps1(RLIP-BD) was injected alone (Fig. 8F). This further
confirms that the interaction between XRLIP and Xreps1(253)
occurs in embryos, and that when XRLIP is located in the plasma
membrane it can recruit Xreps1(253).
Discussion
Using a two-hybrid screening approach, several putative
partners of XRLIP expressed during early development were
isolated. One of them is the Xenopus ortholog of Reps1. In
agreement with what had previously been shown [15], interaction
between Reps1 and RLIP is specific and is evolutionarily
conserved. Using GST pull-down and co-immunoprecipitation
assays, we confirmed that this interaction in Xenopus is regulated
during early development. Moreover, the interacting domain of
each partner was redefined. Previously [15], the Reps-BD of
RLIP76 was defined by the last 476 amino acids of the protein. It
is shown here that the 78 C-terminal amino acids of Xreps1 are
necessary and sufficient to bind XRLIP. These results support a
model in which the coiled-coil sequence of Reps1 participates in
binding to RLIP. However, this coiled-coil sequence is not
composed of perfect L(66)L repeats and it has been proposed that
the coiled-coil region of Reps1 alone is not sufficient to interact
with RLIP [15]. The C-termini of Reps1 and POB1/Reps2 also
have predicted coiled-coil regions, and their alignment shows that
the last 70 C-terminal residues are 86% identical. Thus, since the
coiled-coil region of Reps1 alone, which comprises 50% of this
domain, does not interact with RLIP, the RLIP binding region
could be located between residues 475 and 492 at the C-terminus,
or might only partially overlap the predicted coiled-coil domain.
This C-terminal part of RLIP involved in the production of a
phenotype during early development can be divided into two
distinct domains, one defined by the segment 330–476, the
expression of which affects cell division (unpublished results), and a
more restricted domain encompassing the segment 475–492 that
interacts with Reps1 and induces hyperpigmentation of cells later
in development.
Over-expression in embryos of the most N-terminal 513 amino
acids of Xreps1(253) or of the full-length Mreps1, does not affect
development in any obvious way. Xreps1(RLIP-BD) but not
Xreps1(253) can suppress the phenotype induced by over-
expression of the XRLIP truncated versions (330-Cter), (172–
495) or (469-Cter) containing the CAAX sequence. Consequently,
these proteins interact, and Xreps1 or at least its 513 C-terminal
amino acids are required for the phenotype to appear.
Furthermore, the region of XRLIP corresponding to amino acids
475 to 492 is necessary for the interaction with Xreps1(253) and is
involved in the XRLIP-induced phenotype. Indeed, when
XRLIP(330-Cter)-CAAX or XRLIP(172–495)-CAAX are coin-
jected with Xreps1(RLIP-BD) they increase the effect of XRLIP-
CAAX on pigmentation, while their co-injection with Xreps1(R-
LIP-BD) rescues or almost completely suppresses the hyperpig-
mentation phenotype. Moreover, co-injection of XReps1(253)
with these truncated mutants of XRLIP partially restores the
hyperpigmentation and cell division phenotypes. Consequently,
Xreps1 is required to establish these phenotypes and the N-
terminal part not encoded by the partial cDNA XReps1(253) of
Xreps1 is not necessary for this effect. Dominant positive XRLIP-
CAAX deletion mutants, containing the 476 C-terminal amino
acids of XRLIP such as (330-Cter), (469-Cter), recruit proteins
such as Xreps1(253) that might participate in establishing an
extensive array of protein interactions. However, the effect of the
mutant XRLIP(330-Cter)-CAAX on cell division cannot be due to
the action of Xreps1 because XRLIP(469-Cter) induces only the
hyperpigmentation phenotype. This conclusion is confirmed by
the phenotype induced by the expression of a deletion mutant
containing only the sequence 330–476, for which only cytokinesis
is disturbed (manuscript in preparation).
Injection of a deletion mutant of XRLIP(172–495)-CAAX
composed of RhoGAP domain and the RalBD can produce the
same effects as XRLIP(330-Cter)-CAAX. As mentioned above,
the subcloned domains of XRLIP slightly overlap to some extent.
Thus, the XRLIP(172–495)-CAAX mutant overlaps the first 26
residues of XRLIP(469-Cter) as defined by the group of Feig [15].
Indeed, interaction with Xreps1(253) is possible as shown by the
two-hybrid technique. This result is at least partly confirmed by
the absence of interaction in the two-hybrid system of Xreps1(253)
with the XRLIPDm2( D 475–492) mutant corresponding to the
deletion of the overlapping region between the RalBD and Reps
domains.
Xreps1 cannot suppress the phenotype induced by full-length
XRLIP-CAAX, even though this mutant possesses an intact
Xreps1(RLIP-BD). Thus, Reps1 would be a component of a
different pathway not involved in the early phenotype as shown by
the absence of phenotype when Xreps1(RLIP-BD) is injected. The
disrupted early pathway would lead to remodeling of the F-actin
cytoskeleton, since cortical actin disruption is observed only when
XralB G23V, XRLIP-CAAX or C-terminally truncated XRLIP-
CAAX mutants are over-expressed. The late pathway would
involve Reps1 and have an impact on different targets not leading
Figure 8. Xreps1 protein interacts with XRLIP-CAAX at the
plasma membrane. Representative confocal micrographs of animal
caps dissected at the 2000-cell stage, showing the distribution of Myc-
Xreps1(RLIP-BD)-CAAX expressed alone (A) or in the presence of
XRLIP(379-Cter)-CAAX (G). Myc-Xreps1(RLIP-BD) mRNA (1 ng) and
XRLIP(379-Cter)-CAAX (0.5 ng) were microinjected into the animal
hemisphere of 2-cell stage embryos and Myc-Xreps1(RLIP-BD) was
visualized with an FITC anti-Myc antibody. The animal caps were fixed
and Myc-XRLIP(379-Cter)-CAAX and Myc-Xreps1(RLIP-BD) immuno-
stained with an FITC anti-Myc antibody, (panels A, D and G stained in
green), the F-actin with phalloidin-rhodamine, (panels B, E and H
stained in red) and the merge of Myc-FITC with phalloidin-rhodamine
are shown (panels C, F and I). Scale bars represent 50 mm.
doi:10.1371/journal.pone.0033193.g008
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seems virtually untouched in XRLIP(330-Cter)-CAAX injected
embryos.
The confocal microscopy analysis of the cellular location of
XRLIP suggests a dynamic pattern. XRLIP appears to be located
at first throughout the cell. It is then gradually excluded from a
central (perinuclear) zone that expands towards the periphery of
the cell. The localization pattern of XRLIP and that of
Xreps1(253) are strikingly similar. Either each protein is positioned
by independent mechanisms, or the two proteins are located in the
same complex. However, biochemical evidence argues against the
latter possibility because no significant amount of the XRLIP/
Xreps1(253) complex was detected in vivo, at least during the pre-
MBT stages (unless the interaction is very dynamic, i.e. low affinity
constant for the in vivo interaction).
Within the limits of sensitivity of the pull-down technique and
before the MBT stage, endogenous XRLIP does not seem to
interact with Xreps1(253). The XRLIP used for co-immunopre-
cipitation was unmodified in its C-terminal amino acids, but for
other analyses such as phenotypic tests and confocal microscopy,
XRLIP was fused to CAAX. Therefore, in the cytosol, XRLIP
might undergo post-translational modifications modulating its
interaction with Xreps1. Interestingly, targeting of XRLIP to the
plasma membrane might restore accessibility of the protein to the
Reps1 binding site or increase the interaction between these two
proteins.
The nature of the targets of Reps1 remains speculative. Based
on the data of the structurally related protein POB1/Reps2, Reps1
might interact with essential proteins of the receptor-mediated
endocytotic pathway. It seems unlikely that a mechanism such as
receptor-mediated endocytosis plays a role in early pre-MBT
development that is characterized by a succession of mitoses.
Moreover, the first manifestation of signaling activity, defined by
the expression of the earliest gene does not occur before stage 8.
Additionally, endocytosis would be less active during mitosis [32],
since it has been shown that many endocytotic proteins are
phosphorylated during mitosis so as to down-regulate this process.
Indeed, the Epsin/Eps15/POB1 complex is disrupted by phos-
phorylation. The group of Camonis [33] has shown that RLIP
facilitates phosphorylation of Epsin, a target of Reps1, by cdk1,
reinforcing the possibility that RLIP and Reps1 would not interact
before the establishment of a complete cell cycle with G1 and G2
phases at the MBT stage. To explore a putative protein interaction
network with RLIP, liquid chromatography/electrospray ioniza-
tion tandem mass spectrometry was used. Among the groups of
genes forming different complexes interacting with RLIP,
filaggrin, has been identified through a peptide of 13 amino acids
and the analysis yields a score of 43 with the ‘‘mascot’’ program.
Other groups of peptides have been selected for their interactions
with RLIP with scores above 30, such as 7 peptides coding for
Reps1 with scores between 30 and 62, one peptide of 10 amino
acids coding for POB1/Reps2 with a score of 41, and 6 peptides of
12 amino acids coding for RalA with scores comprised between 34
and 54. During the cleavage stage, up to MBT, Ral, RLIP and
Reps are present in embryo (Fig. 9A), but no interaction is
detected. However, from MBT, Ral interacts with RLIP and
recruits it at the plasma membrane (Fig. 9B). It has been proposed
that through Cdc42 RLIP destabilizes actin cytoskeleton and
through its interaction with m2 of AP2 complex it allows
endocytosis at clathrin. At this stage of development RLIP
interacts also with Reps1 (Fig. 9B9), but this interaction could be
exclusive of ectodermic cells and could use another partner, the
filaggrin (Fig. 9C). Filaggrin is known to be associated with skin
barrier abnormalities [34] and its deficiency leads to a leaky skin
barrier [35]. This function of filaggrin can be related to our
observation of loss of ectodermal cells when XRLIP-CAAX and
Xreps1(253) are co-overexpressed. In mice, the skin barrier
appears relatively late in development at stage (E16) [36]. In
Xenopus, the bilayer epithelium ectoderm is generated during the
blastula stage [37] before hatching, and could explain why
desquamation of embryos before hatching was observed (Fig. 7
Ak). Since no specific spatial expression of Reps1 was detected in
embryos, Reps1, similary to RLIP or some effectors of FGF
signaling pathway, is not active by itself, but through its interaction
with RLIP. Such interaction might be controlled by a post-
translational modification of RLIP or Reps1 itself.
In summary, our results indicate that the 78 C-terminal residues
of Xreps1 interact with the 475 last amino-acids in C-terminal part
Figure 9. Hypothetical model of the interaction of Reps with RLIP during early development. (A) During cleavage stage, and up to MBT,
Ral, RLIP and Reps are present in embryo; however no interactions are detected between them. (B) As of MBT, Ral interacts with RLIP and recruits it at
the plasma membrane. It is thought that through Cdc42 it destabilizes the actin cytoskeleton and through m2 and consequently AP2 allows
endocytosis via clathrin. At this stage of development RLIP interacts also with Reps1, but (C) this interaction could be exclusive of ectodermic cells
and could use another partner, such as filaggrin.
doi:10.1371/journal.pone.0033193.g009
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stage, which is defined by active mitotic activity, but only from
gastrulation. Differential formation of the RLIP and Reps1
complex indicates that this interaction is not constitutive but that
it is developmental-stage specific. The underlying mechanisms
controlling the formation of this complex remains to be described.
Moreover, the persistent defect specifically induced by Reps-
CAAX in ectodermic cells of embryos could suggest that Reps is
functional in ectodermic cells.
Materials and Methods
Ethics statement
Our work uses early Xenopus embryos. All experimental
procedures described in this study followed the recommendations
of the ‘‘Comite ´ National de Re ´flexion Ethique sur l’Experimen-
tation Animale’’ of the Ministry of Higher Education and
Research and were approved by the ‘‘Comite ´ d’Ethique Buffon’’
license Nu CBE-009-2011, covering all the ethical aspects. This
work required no other license.
Cloning
All cDNAs used for microinjection purposes were subcloned
into the vector pRN3 [24] that contains the 59 and 39 untranslated
regions of the Xenopus globin gene and a poly(A) tail. Plasmids were
linearized with the restriction enzyme Asp718 prior to RNA
synthesis.
The various XRLIP mutants, namely XRLIP(469-Cter),
XRLIP(172–495), XRLIP(330–Cter), XRLIP-CAAX and the
Xreps1 mutants Xreps1(RLIP-BD) and Xreps1(DRLIP-BD), were
PCR-amplified using primers containing convenient restriction
sites and encoding or not the XralB-CAAX motif, and were
subcloned into pRN3 containing two in frame Myc-Tags. All the
constructs were verified by sequencing to exclude the presence of
PCR-induced mutations.
For the two-hybrid interaction tests all XRLIP mutants without
the CAAX motif were subcloned into pNLX3. Xreps1(253),
Xreps1(RLIP-BD), and Xreps1(DRLIP-BD) were subcloned into
pGAD-GE. RLIP76 cloned into pNLX3 was a kind gift of J.
Camonis.
For the GST pull-down experiments, wild-type XRLIP, Xreps1
and Xreps1(RLIP-BD) were subcloned into pGEX-4T-1 (Phar-
macia). The clone pGEX-RalA G23V was kindly supplied by J.
Camonis.
Yeast two-hybrid screen
The yeast strains L40 and AMR70 were kindly provided by J.
Camonis. The host yeast strain was L40 (MATa, trp1, leu2, his3,
LYS2::lexA-HIS3, URA::lexA-lacZ). RLIP76 cDNA cloned in the
vector pNLX3 was used as bait for library screening. This
construct codes for the human RLIP fused at is C-terminus to the
DNA-binding domain of the LexA protein, previously modified to
contain a nuclear localization signal. The Xenopus oocyte cDNA
library was constructed using the vector pGAD-GE [25]. The two-
hybrid screen was carried out as previously described [25].
For interaction specificity studies, one of the two following
methods was used: i) the L40 strain containing the pGAD-based
constructs was mated with the AMR70 strain (MATa, trp1, leu2,
his3, LYS2::lexA-HIS3, URA::lexA-lacZ) containing the pNLX3-
based constructs, or ii) the L40 strain was co-transformed with
pairs of pNLX- and pGAD-based constructs. Diploids or co-
transformants were tested for His
+ (auxotrophy) and LacZ
+
expression, and growth in selective medium.
mRNA synthesis and embryo microinjection
Xenopus were purchased from the CNRS frog colony (Rennes,
France). Embryos were fertilized in vitro and dejellied with 2%
cysteine-HCl in 0.36modified Barth’s solution at pH 7.6 (MBS)
[26], and incubated in 16 MBS. Capped mRNAs were
synthesized using the T3 mMessage mMachine System Kit
(Ambion) and the mRNAs were subjected to sequential precipi-
tation with 0.5 M ammonium acetate followed by 2.5 M LiCl to
remove unincorporated nucleotides. Microinjections, using a
Drummond microinjector, were performed at the two-cell stage
in the animal pole in 16 MBS with 2% Ficoll unless stated
otherwise. Embryos were transferred to 0.16MBS with 2% Ficoll,
4 h after injection, and incubated at 16–18uC until the desired
stage was reached.
Western blots
Embryos were harvested at stage 6–7, according to Nieuwkoop
and Faber [27], and lyzed in 40 ml of buffer D (50 mM Tris-HCl
pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1% Triton X-100, 1 mM
PMSF) per embryo by pipetting up-and-down several times, then
treated twice with the same volume of Freon (Merck) to remove
the yolk [28]. The crude protein extracts were mixed with
Laemmli buffer and subjected to SDS-PAGE. The proteins were
then transferred to PVDF membranes (Hybond-P, Amersham)
and probed overnight with the appropriate antibodies (Santa Cruz
Biotechnology). Signals were detected by chemioluminescence
(ECL, Amersham) after incubation with peroxidase-conjugated
secondary antibodies (Sigma).
In vitro protein synthesis
Myc-XRLIP, Myc-Xreps1(253), Myc-Xreps1(RLIP-BD), and
XralB G23V proteins were synthesized using the reticulocyte
extract TnT Kit (Promega) and labelled with [
35S] methionine
(ICN) according to manufacturer’s instructions.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as described
[29] with reps1 and with chordin as control. After satisfactory
color development, embryos were fixed in MEMFA (0.16 M
MOPS pH 7.4, 2 mM ethylene diamine tetra-acetic acid and
3.7% formaldehyde) for 1 h at room temperature, washed, and
stored in 100% ethanol. Embryos were also treated in 10% H2O2
to bleach the pigment.
Synthesis and purification of the GST-fusion proteins
cDNAs coding for XRLIP, Xreps1(253) and Xreps1(RLIP-BD)
were cloned fused to the open reading frame of GST in the
pGEX-4T-1 vector. Protein synthesis was induced by 1 mM IPTG
(Euromedex). Bacterial clones containing GST-RalA G23V were
subsequently incubated at 37uC, whereas clones containing GST-
XRLIP, GST-Xreps1(253) and GST-Xreps1(RLIP-BD) were
incubated at 30uC to limit protein degradation. When the
appropriate incubation time was reached, the cultures were
centrifuged and the bacterial pellets were resuspended in buffer D.
Cell lysis was achieved by adding 1 mg/ml lysozyme (Euromedex),
and after incubation for 1 h at 4uC, the samples were sonicated
and centrifuged at 4uC for 45 min at 14000 rpm, to remove cell
debris and insoluble material. The supernatants were immediately
used.
Recombinant GST-proteins were purified on glutathione
Sepharose 4B (Amersham) at room temperature in buffer D as
described by the manufacturer. The purified products were
analyzed by SDS-PAGE and the concentration of the purified
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blue staining using a BSA standard.
GST pull-down assays
GST pull-down assays were carried out using 2 mg of GST-
XRLIP, GST-Xreps1(253) or GST-Xreps1(RLIP-BD). Controls
were carried out with 5 mg of GST-RalA G23V. This small G
protein was preloaded with GTP-g-S in Mg-free loading buffer
(20 mM Tris-HCl pH 7.5, 25 mM NaCl, 10 mM EDTA, 1 mM
DTT, 0.05% BSA and 1 mM GTP-g-S) for 1 h at 37uC prior to
use. Addition of 20 mM MgCl2 stopped the reaction. Using this
method, the yield of GTP loading was estimated to be 30%. The
embryos were lyzed in buffer D and treated twice with Freon.
Reticulocyte extracts were diluted in buffer D. Crude protein
extracts were pre-incubated with 5 mg of GST alone in buffer D
for 1 h at room temperature and centrifuged. The supernatants
were then incubated with the corresponding GST-fusion protein
for 2–3 h at room temperature and centrifuged. All pellets were
washed 3 times with ice-cold buffer D and resuspended in
Laemmli buffer prior to Western blot analysis.
Co-immunoprecipitation assays
Embryos were injected with mRNA coding for the appropriate
Myc-tagged protein. At the 2000 cell stage, proteins were
extracted by lysis of 15 to 20 embryos in 800 ml of buffer
(50 mM Tris-HCl pH 7.5, 100 mM NaCl and 2 mM PMSF).
After incubation for 15 min in ice, the extracts were centrifuged at
13,000 rpm for 30 min. The supernatants were incubated with
slow shaking at 4u in the presence of 3 ml of anti-myc monoclonal
antibody (anti c-Myc (9E10), Santa Cruz) already bound to
agarose and centrifuged at 13,000 rpm for 6 min. The superna-
tant was discarded and 32 mlo f1 6Laemmli buffer were added to
the pellet. The precipitated proteins were separated by SDS-
PAGE and transferred onto a PVDF membrane for Western
blotting.
Confocal microscopy
The vitelline membrane of selected embryos was removed
manually and the embryos were permeabilized for 15 min at room
temperature in 80 mM Hepes, pH 6.8, 1 mM MgCl2, 100 mM
EDTA, 30% glycerol and 0.1% Triton X-100 and fixed in 16
PBS and 3.5% formaldehyde, for 1–2 h at room temperature. The
embryos were then incubated in saturation buffer (16 PBS, 1%
BSA) for 5 h at room temperature under mild shaking.
Immunostaining was carried out on explants with c-Myc antibody
(9E10) (dilution 1:1000 in 16PBS, 1% BSA and 0.1% Triton X-
100), followed by FITC-conjugated secondary antibodies (Jackson
Immuno-research). Animal caps were manually dissected and
treated with rhodamine-phalloidin (7.5 mg/ml (Cytoskeleton)).
They were washed in 16 PBS and 0.1% Triton X-100, and
mounted in Citifluor medium. Observations were carried out with
a Leica TCS-4D laser confocal microscope (Leica Instruments).
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